Skip to main content
Veterinary Medicines

CARPRODYL QUADRI 120 MG CHEWABLE TABLETS FOR DOGS

Authorised
  • Carprofen

Product identification

Medicine name:
CARPRODYL QUADRI 120 MG CHEWABLE TABLETS FOR DOGS
Carprodyl Quadri 120 mg kauwtabletten voor honden
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    120.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Cardboard box with 2 blisters of 6 tablets
  • Cardboard box with 80 blisters of 6 tablets
  • Cardboard box with 40 blisters of 6 tablets
  • Cardboard box with 20 blisters of 6 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CEVA Sante Animale B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 104084
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0172/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 23/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."